Evaluation of nephroprotection of silymarin on contrast-induced nephropathy in liver cirrhosis patients: A population-based cohort study

Recent findings from an animal experiment suggest a modest association between silymarin and decreased risk of contrast-induced nephropathy. However, the relationship between silymarin and contrast-induced nephropathy in patients with liver cirrhosis remains unclear. From 1997 to 2007, we identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Yu-Jui, Chang, Hui-Ping, Chang, Yu-Jun, Wu, Hsing-Hsien, Chen, Chang-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155955/
https://www.ncbi.nlm.nih.gov/pubmed/30212956
http://dx.doi.org/10.1097/MD.0000000000012243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155955/
https://www.ncbi.nlm.nih.gov/pubmed/30212956
http://dx.doi.org/10.1097/MD.0000000000012243

Ejemplares similares